NewEdge Advisors’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$679 Hold
23
﹤0.01% 4031
2026
Q1
$538 Sell
23
-45
-66% -$815 ﹤0.01% 3980
2025
Q4
$965 Hold
68
﹤0.01% 3988
2025
Q3
$1.68K Sell
68
-74
-52% -$1.65K ﹤0.01% 3810
2025
Q2
$3.22K Hold
142
﹤0.01% 3509
2025
Q1
$4.3K Sell
142
-3
-2% -$114 ﹤0.01% 3338
2024
Q4
$5.75K Sell
145
-4,808
-97% -$217K ﹤0.01% 3193
2024
Q3
$314K Buy
4,953
+4,662
+1,602% +$337K ﹤0.01% 1775
2024
Q2
$19.7K Sell
291
-226
-44% -$15.8K ﹤0.01% 2629
2024
Q1
$41K Buy
517
+245
+90% +$20K ﹤0.01% 2380
2023
Q4
$21.1K Buy
+272
New +$20.1K ﹤0.01% 2556
2023
Q2
Sell
-5,316
Closed -$384K 3478
2023
Q1
$384K Sell
5,316
-4,519
-46% -$352K ﹤0.01% 1233
2022
Q4
$801K Buy
9,835
+1,159
+13% +$95.5K 0.02% 587
2022
Q3
$678K Buy
8,676
+3,452
+66% +$276K 0.01% 819
2022
Q2
$353K Buy
+5,224
New +$364K 0.01% 1149
2017
Q3
Sell
-205
Closed -$10.2K 383
2017
Q2
$10.2K Buy
+205
New +$9.08K ﹤0.01% 955

Other funds holding ACHC

NewEdge Advisors's ACHC Position: Q2 2026 in Review

NewEdge Advisors held its Acadia Healthcare (ACHC) position steady in Q2 2026 at 23 shares worth $679. The position accounts for ﹤0.01% of the portfolio, ranked #4031.

NewEdge Advisors first reported a position in ACHC in Q2 2017 and has held it in 16 quarters since. The position peaked at $801K in Q4 2022. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

  • NewEdge Advisors held 23 shares of Acadia Healthcare worth $679 as of Q2 2026.
  • NewEdge Advisors left its Acadia Healthcare share count unchanged in Q2 2026.
  • Acadia Healthcare made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #4031 holding.
  • NewEdge Advisors first reported a position in Acadia Healthcare in Q2 2017 and has held it in 16 quarters since.
  • NewEdge Advisors's Acadia Healthcare position peaked at $801K in Q4 2022.
  • 314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.